Encore Dermatology Inc. Launches TridesilonTM (desonide) Cream, 0.05% for AD

Encore Dermatology Inc. is rolling out Tridesilon^TM (desonide) Cream, 0.05% in a 60g tube for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Encore Dermatology Inc. licensed Tridesilon^TM Cream, 0.05% from Perrigo Company plc. It is available in the U.S. by prescription only. Tridesilon^TM Cream, 0.05% should not be used for longer than two weeks unless directed by a physician. It is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Tridesilon^TM Cream, 0.05% joins other Encore Dermatology products including HylatopicPlus^® Cream or Lotion and Tetrix^® Cream. Tridesilon^TM Cream, HylatopicPlus^® and Tetrix^® Cream are not indicated for combination use.